KEYNOTE-689 established perioperative pembrolizumab (two preoperative cycles) as event-free survival–improving therapy for resectable, locally advanced disease, supporting FDA approval and adoption ...
Dr. Ranee Mehra shares guidance on recurrence, quality-of-life concerns and clinical trials for patients with head and neck cancers and caregivers. In an interview with CURE, Dr. Ranee Mehra, director ...
A large clinical study recently published in The Lancet showed that patients treated with proton therapy for oropharyngeal cancers (cancers of the upper throat including the tonsils and back of the ...
Medical imaging routinely used in cancer care may hold far more biological information than previously thought.
Head and neck cancers display notable heterogeneity in their immune cell infiltrates, which reflect intricate spatial arrangements and dynamic networks of ...
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Two new studies, published ...
A research team led by the Medical University of Vienna has demonstrated in a recent study that the biological characteristics of a subgroup of head and neck tumors - which are very aggressive in many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results